RESEARCH OVERVIEW
What is CJC-1295 No DAC?
CJC-1295 No DAC is a catalogue name that requires careful interpretation against the scientific literature. Many prominent CJC-1295 papers studied a long-acting, albumin-binding molecule that contains a drug-affinity-complex-related modification. Those results must not be assigned directly to a material labelled “No DAC”.
CJC-1295 No DAC 10 mg — product details
This listing is for CJC-1295 No DAC 10 mg, product code JG-MIG-027. The 10 mg figure is the listed material quantity, not a recommended dose or a concentration. Review this strength’s label and matching batch record when planning a laboratory assay.
LISTED CONTENT
10 mg
PRODUCT CODE
JG-MIG-027
INTENDED USE
Laboratory research
Research focus and areas of interest
GHRH-analogue research context
The long-acting CJC-1295 studies investigated growth-hormone and IGF-1 responses or serum-protein patterns. They are included as related-analogue context, not as direct evidence for this No DAC product. The albumin-binding chemistry is central to their prolonged-exposure findings. [1]
Sequence-based identification
An analytical report identified a 29-amino-acid, C-terminally amidated peptide in an unknown preparation. Such work illustrates why sequence and modification data are more informative than a marketing name when determining which experimental literature is applicable. [3]
Analytical methods for GHRH-related peptides
Urine and equine-plasma methods investigated GHRH analogues using extraction and mass spectrometry. Some methods specifically concern conjugated, long-acting CJC-1295. These are useful identity and detection references, but not clinical-efficacy studies for No DAC material. [4]
Evidence and limitations
The five references are deliberately labelled as related-analogue or analytical literature. They are not five trials of this exact No DAC product. Long-acting CJC-1295 half-life values, dosing schedules and clinical findings cannot be transferred to No DAC material without appropriate evidence.
Scientific references describe the material and methods used by their authors. They do not certify this product’s purity, sterility, identity or suitability for a particular experiment. A related analogue, delivery system or combination is not automatically equivalent to the supplied peptide.
Technical identity and documentation
Request the complete sequence, terminal modifications and explicit confirmation of DAC absence. Establish the exact relationship to modified GRF(1-29) through the batch documentation rather than assuming all names refer to the same molecule.
For this product’s identity and batch results, visit the COA and documentation page or contact JGPEP+ with the product and batch numbers. Literature values should not replace a matching analytical certificate.
Storage and laboratory handling
Follow the product label and batch-specific supplier instructions. Confirm temperature, solvent compatibility, stability and any reconstitution requirements before use. Storage conditions reported for another supplier or a clinical formulation should not be applied automatically to this material.
Research references
Original studies and analytical papers are linked below. Study type is included so that laboratory models, clinical research and related-analogue evidence can be distinguished.
1. Long-acting CJC-1295 endocrine study—DAC context. Teichman SL et al. 2006 Mar. The Journal of clinical endocrinology and metabolism. Related DAC-analogue clinical study. PubMed PMID 16352683 · Publisher / DOI
2. Long-acting analogue serum-protein analysis—DAC context. Sackmann-Sala L et al. 2009 Dec. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society. Related DAC-analogue human study. PubMed PMID 19386527 · Publisher / DOI
3. Sequence identification in an unknown preparation. Henninge J et al. 2010 Nov-Dec. Drug testing and analysis. Analytical identity study. PubMed PMID 21204297 · Publisher / DOI
4. Analytical detection of GHRH analogues. Cristea CD et al. 2023 Dec 1. Analytical biochemistry. Related-analogue analytical study. PubMed PMID 37806509 · Publisher / DOI
5. Conjugated CJC-1295 detection in equine plasma. Timms M et al. 2019 Aug. Drug testing and analysis. Related DAC-analogue analytical study. PubMed PMID 30938069 · Publisher / DOI
For laboratory research only. Not for human or veterinary consumption or administration. This information is scientific background, not medical advice or an administration guide.
Reviews
There are no reviews yet.